I am/have/had
I am looking for
Advanced Filters
Found 2 clinical trials
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
This is an international multicenter, open-label, randomized phase III trial including three sequential randomizations to assess efficacy of induction and consolidation chemotherapies and radiotherapy for patients with high-risk neuroblastoma.
dyspnea
arrhythmia
bowel obstruction
high-risk neuroblastoma
bone lesions
- 0 views
- 16 Feb, 2024
- 1 location
Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of Osteosarcoma
Study objective is to compare the efficacy and safety of camrelizumab in combination with adriamycin, cisplatin, ifosfamide and methotrexate in study population in China. Camrelizumab is a humanized anti-PD1 IgG4 monoclonal antibody.
methotrexate
hepatitis c
ifosfamide
adriamycin
monoclonal antibodies
- 0 views
- 16 Feb, 2024
- 1 location